# PulmoVision — Final Project Sign-off & Decision Review

**Date:** November 12, 2026  
**Auditor / Reviewer:** Senior ML Research Engineer, Software Architect, QA Lead, and Git Release Reviewer  
**Repository:** `PulmoVision`  
**Active Branch:** `feature/cnn-bilstm`  
**Current HEAD Commit:** `68b5a1d`  
**Target Milestone:** Stage 2 CNN-BiLSTM Research, Inference Engine & Modular Streamlit Application  
**Report Location:** `reports/experiments/FINAL_PROJECT_SIGNOFF_REPORT.md`

---

## 1. Executive Summary

This document establishes the authoritative, evidence-based final sign-off audit for the PulmoVision thoracic CT sequence intelligence platform. All findings, metrics, and assessments are derived from direct inspection of the repository, source files, automated test suites, and git revision history.

### Core Findings Summary
1. **Research & Modeling (Complete):** The Stage 2 CNN-BiLSTM research benchmark has concluded. Across 15 rigorous outer/inner cross-validation runs, **Architecture B (EfficientNet-B0 + BiLSTM + Global Mean Pooling)** emerged as the clear empirical leader (Macro F1: $0.9461$, ROC-AUC: $0.9688$, Sensitivity: $98.70\%$, Specificity: $88.89\%$, 1 false negative out of 77 COVID-19 patients).
2. **Deployment Artifact (Frozen & Verified):** The standalone development deployment checkpoint `models/stage2_bilstm_deployment.pth` is verified with SHA-256 hash `0bd817319d99e0fbb22a318c458d9f86df77297f7bc4f5ec88f845e80ff1caed` ($1,460,418$ parameters).
3. **Application & UI Architecture (Complete & Modular):** The application has been fully re-engineered from a monolithic script into 7 modular view destinations (`app/views/`), 7 reusable UI component packages (`app/components/`), and centralized styling/token managers (`app/styles/`). All emojis have been eliminated (0 unicode emojis across the entire UI codebase) in favor of Streamlit Material Symbols and vector SVGs. Both **Clinical Dark** and **Laboratory Light** themes are operational, maintaining a pitch-black (`#000000`) radiological canvas invariant.
4. **Dataset Explorer & Defect Resolution (Verified):** The manifest loading `KeyError` was resolved through the introduction of [`ManifestAdapter`](file:///Users/geetikavasistha/PulmoVision/app/utils/manifest_adapter.py), enabling real-time search across 122 patients and 239 acquisition series, label filtering (77 COVID-19 vs 45 Normal patients), and inspection of 604 duplicate slice aliases.
5. **Quality Assurance & Verification (100% Green):** The automated test suite stands at **95 / 95 passing tests** across 15 test modules. Real-data acceptance verification on 16-bit TIFF series (`patient1_SR_2`) validated sequence ordering, patient consistency, inference execution, and latency reporting ($132.9\text{ ms/slice}$).
6. **Strict Test Quarantine (100% Preserved):** The held-out test partition `data/metadata/Annotation/CSV/test1.csv` remains completely sealed, unopened, unread, and unmodified in git status.

---

## 2. Verified Repository State

Direct read-only inspection of the repository environment on November 12, 2026 establishes the following:

### Git Topology and Branch Status
- **Current Branch:** `feature/cnn-bilstm`
- **HEAD Commit:** `68b5a1d` — *"feat(app): complete modular redesign of research laboratory and clinical workstation"*
- **Branch Inventory (All 5 Preserved):**
  1. `main` (at `8803327`, *"docs: finalize Stage 2 CNN-BiLSTM architecture and nested CV protocol"*)
  2. `feature/cnn-bilstm` (at `68b5a1d`, active feature branch)
  3. `feature/streamlit-deployment` (at `f53404d`)
  4. `feature/model-development` (at `5488c29`)
  5. `feature/evaluation-xai` (at `406eb87`)
- **Divergence Analysis:**
  - `git rev-list --count feature/cnn-bilstm..main` = `0` (main has no commits ahead of the feature branch).
  - `git rev-list --count main..feature/cnn-bilstm` = `8` (feature branch is strictly 8 commits ahead of main).
  - Merging `feature/cnn-bilstm` into `main` is cleanly achievable with zero conflicts.

### Working Tree Status
The working tree contains 27 modified files and 4 untracked files resulting from the UI modularization, manifest adapter repair, zero-emoji icon migration, and test expansion:

- **Modified Files (27):**
  - `app/components/` (7 files: `architecture_diagrams.py`, `charts.py`, `ct_viewer.py`, `header.py`, `metric_cards.py`, `navigation.py`, `tables.py`)
  - `app/views/` (7 files: `overview_view.py`, `dataset_view.py`, `models_view.py`, `analytics_view.py`, `workstation_view.py`, `explainability_view.py`, `documentation_view.py`)
  - `app/styles/theme.py`, `app/utils/data_loader.py`, `app/streamlit_app.py`
  - `docs/PROJECT_PROGRESS.md`
  - `reports/figures/` (8 files: refreshed high-resolution screenshots `01` through `08`)
  - `tests/test_ui_modules.py`
- **Untracked Files (4):**
  - `app/utils/manifest_adapter.py` (New manifest normalization engine)
  - `reports/experiments/FINAL_UI_IMPLEMENTATION_REPORT.md` (UI implementation documentation)
  - `scripts/verify_acceptance.py` (Acceptance verification script)
  - `tests/test_manifest_adapter.py` (10 unit tests for manifest adapter)
- **Staged Files:** None (`0` files staged).
- **Excluded Files Confirmed:** No raw datasets, model weights, cache files, virtual environments, or secrets are tracked or staged.

### Deployment Checkpoint Integrity
- **Target File:** `models/stage2_bilstm_deployment.pth`
- **Computed SHA-256:** `0bd817319d99e0fbb22a318c458d9f86df77297f7bc4f5ec88f845e80ff1caed`
- **Expected Hash:** `0bd817319d99e0fbb22a318c458d9f86df77297f7bc4f5ec88f845e80ff1caed`
- **Integrity Status:** **VERIFIED MATCH** (matches `tests/test_ui_modules.py:180` and `FINAL_IMPLEMENTATION_AUDIT.md`).

---

## 3. Research and Model Readiness

### Benchmarking Evidence
Stage 2 5-fold outer cross-validation with inner validation holdouts evaluated three architectures across the exact same patient-level folds ($77$ COVID-19, $45$ Normal patients, $3,132$ canonical slices):

| Architecture ID | Model Architecture | Macro F1 | ROC-AUC | PR-AUC | Sensitivity | Specificity | False Negatives |
| :--- | :--- | :---: | :---: | :---: | :---: | :---: | :---: |
| **Experiment A** | EfficientNet-B0 + Mean Pooling (Baseline) | $0.8236$ | $0.8652$ | $0.9046$ | $77.92\%$ | $91.11\%$ | $17 / 77$ |
| **Experiment B** | EfficientNet-B0 + BiLSTM + Mean Pooling | **$0.9461$** | **$0.9688$** | **$0.9760$** | **$98.70\%$** | $88.89\%$ | **$1 / 77$** |
| **Experiment C** | EfficientNet-B0 + BiLSTM + Additive Attention | $0.9211$ | $0.9466$ | $0.9466$ | $93.51\%$ | **$91.11\%$** | $5 / 77$ |

### Model Readiness Assessment
- **Architecture B** demonstrates conclusive superiority for clinical screening research by reducing false negatives from 17 down to a single missed case ($98.70\%$ sensitivity) while maintaining high specificity ($88.89\%$).
- The deployment checkpoint is properly trained on the full development cohort, serialized, and integrated into `SequencePredictor`.
- **Operating Threshold:** Fixed at $\tau = 0.50$, matching the audited cross-validation benchmark protocol.
- **Explainability:** Grad-CAM saliency maps and temporal attention visualizations are documented and contextualized with clinical caveats regarding non-specificity.

---

## 4. Dataset Integrity and Holdout Protection

### Deduplication and Provenance
- Forensic SHA-256 analysis identified 604 redundant duplicate slice aliases in the raw development dataset.
- The deduplication manifest (`data/metadata/stage2_dev_deduplicated_manifest.csv`) standardizes $3,132$ canonical anatomical slices.
- `ManifestAdapter` guarantees that both canonical filenames and historical duplicate aliases are transparently accessible in the application without schema crashes.

### Patient-Balanced Training Weights
- Because CT slice counts vary significantly across patients (ranging from 5 to 70 slices per patient), standard slice-level training biases models toward over-sampled individuals.
- In `src/evaluation/nested_cv.py`, patient-balanced weighting ($w_i = 1 / N_p$ per series, grouped per patient) was strictly enforced, ensuring equitable gradient contributions.

### Sealed Holdout Boundary (`test1.csv`)
- **Quarantine Check:** `git status --porcelain data/metadata/Annotation/CSV/test1.csv` returns empty.
- No application view, test, script, or model component imports or references `test1.csv`.
- The test partition remains 100% pristine and uncompromised.

---

## 5. Application and UI Readiness

### UI Modularization
The monolithic application has been decomposed into an enterprise-grade modular structure:
```
app/
├── components/          # Reusable UI widgets (cards, charts, tables, diagrams, viewers)
├── styles/              # Design tokens and theme engine
├── utils/               # Paths, data loaders, and manifest adapter
├── views/               # 7 dedicated destination views
└── streamlit_app.py     # Clean routing and state coordination entrypoint
```

### Icon & Aesthetic Standardization
- **Zero Emojis:** Verified by automated scan in `tests/test_ui_modules.py`. All section headings, navigation links, and badges use Streamlit Material Symbols (e.g., `:material/biotech:`, `:material/dataset:`, `:material/medical_services:`) or inline SVGs.
- **Dual Visual Themes:**
  - *Clinical Dark:* `#0F172A` background, `#1E293B` containers, `#0D9488` teal accents.
  - *Laboratory Light:* `#F8FAFC` background, `#FFFFFF` containers, `#0D9488` teal accents.
- **Radiological Viewport Invariant:** The CT imaging canvas remains pitch black (`#000000`) with high-contrast medical windowing in both themes.

### Live CT Sequence Workstation
- Real 16-bit TIFF slice validation, craniocaudal slider navigation, and sequence inference running against `stage2_bilstm_deployment.pth`.
- Single-slice fallback ($T=1$) is explicitly flagged with clear clinical caveats.
- Latency tracking reports inference runtime ($~133\text{ ms/slice}$).

### Regulatory and Research Disclaimers
- Every page displays a prominent, persistent research disclaimer:
  > *"Educational and scientific research prototype — NOT a medical diagnostic tool. Uncalibrated model scores must not be used for clinical decision-making."*

---

## 6. Test and QA Results

### Automated Pytest Suite
The full regression suite was executed via `./venv/bin/pytest`:
- **Result:** **95 / 95 passed (100% green)** in 13.22 seconds.
- **Module Coverage Breakdown:**
  1. `tests/test_data.py`: 3 passed (TIFF loading, radiodensity scaling)
  2. `tests/test_deduplication.py`: 10 passed (SHA-256 deduplication and manifest verification)
  3. `tests/test_explainability.py`: 2 passed (Grad-CAM extraction and heatmaps)
  4. `tests/test_inference.py`: 2 passed (Single-slice inference pipeline)
  5. `tests/test_manifest_adapter.py`: 10 passed (CSV/JSON schema handling, filtering, search)
  6. `tests/test_models.py`: 10 passed (Backbones, BiLSTM, parameter counts)
  7. `tests/test_patient_evaluation.py`: 2 passed (Patient-level pooling and metrics)
  8. `tests/test_patient_split.py`: 4 passed (Zero patient leakage across folds)
  9. `tests/test_patient_weighting.py`: 6 passed (Loss weighting calculations)
  10. `tests/test_preprocessing.py`: 3 passed (16-bit windowing and augmentations)
  11. `tests/test_sequence_inference.py`: 4 passed (BiLSTM sequence inference)
  12. `tests/test_sequence_validation.py`: 7 passed (Slice ordering and series validation)
  13. `tests/test_stage2_infrastructure.py`: 13 passed (Cross-validation data loaders)
  14. `tests/test_ui_modules.py`: 13 passed (Zero emojis, Material Symbols, checkpoint SHA-256)
  15. `tests/test_upload_validation.py`: 6 passed (Corrupted and invalid sequence rejection)

### Acceptance Verification Script (`scripts/verify_acceptance.py`)
- **Dataset Explorer:** Manifest loaded in 49.1 ms; patient search (`patient124`), series search (`SR_2`), label filtering (77 COVID vs 45 Normal), and duplicate provenance (604 aliases) all passed.
- **CT Workstation:** Real 6-slice 16-bit TIFF sequence (`patient1_SR_2`) validated in 0.12 ms and executed inference in 797.4 ms with 99.98% score.

---

## 7. Commit Decision

### Recommendation: **READY TO COMMIT**

### Reasoning
- The working tree is clean of any unwanted artifacts (no model weights, raw data, caches, or virtual environments).
- All 95 automated unit and regression tests pass cleanly.
- The UI fixes, zero-emoji enforcement, and manifest adapter are thoroughly tested and verified.
- The documentation matches the actual codebase implementation.

### Exact Files to Stage and Commit (31 files):
```bash
git add \
  app/components/architecture_diagrams.py \
  app/components/charts.py \
  app/components/ct_viewer.py \
  app/components/header.py \
  app/components/metric_cards.py \
  app/components/navigation.py \
  app/components/tables.py \
  app/styles/theme.py \
  app/utils/data_loader.py \
  app/utils/manifest_adapter.py \
  app/views/analytics_view.py \
  app/views/dataset_view.py \
  app/views/documentation_view.py \
  app/views/explainability_view.py \
  app/views/models_view.py \
  app/views/overview_view.py \
  app/views/workstation_view.py \
  app/streamlit_app.py \
  docs/PROJECT_PROGRESS.md \
  reports/figures/01_overview_dark.png \
  reports/figures/02_overview_light.png \
  reports/figures/03_dataset_explorer.png \
  reports/figures/04_model_laboratory.png \
  reports/figures/05_experiment_analytics.png \
  reports/figures/06_ct_workstation.png \
  reports/figures/07_explainability.png \
  reports/figures/08_research_documentation.png \
  reports/experiments/FINAL_UI_IMPLEMENTATION_REPORT.md \
  reports/experiments/FINAL_PROJECT_SIGNOFF_REPORT.md \
  scripts/verify_acceptance.py \
  tests/test_manifest_adapter.py \
  tests/test_ui_modules.py
```

### Proposed Commit Message:
```
feat(ui): resolve manifest schema KeyError, standardize Material Symbols icons, and finalize QA
```

### Files Remaining Excluded:
- `data/raw/` (Raw image files)
- `data/metadata/Annotation/CSV/test1.csv` (Sealed test partition)
- `models/*.pth` (Binary weights)
- `venv/`, `__pycache__/`, `.DS_Store`

---

## 8. Merge Decision

### Recommendation: **KEEP ON FEATURE BRANCH** (Pending Human Review), then **MERGE READY**

### Reasoning
- `feature/cnn-bilstm` is strictly ahead of `main` by 8 commits with zero divergence.
- Merging is technically straightforward and will produce zero conflicts.
- However, per standard software governance, the pending working tree changes should be committed to `feature/cnn-bilstm` first. Once the commit is reviewed, a standard merge commit (`--no-ff`) should be used to merge into `main`.

### Recommended Merge Strategy:
Use a standard merge commit (`--no-ff`) to preserve the feature branch history, individual experiment commits, and audit milestones:
```bash
git checkout main
git merge --no-ff feature/cnn-bilstm -m "merge: integrate Stage 2 CNN-BiLSTM research, inference pipeline, and modular UI"
```
*(Do NOT execute without explicit developer authorization).*

---

## 9. Holdout Evaluation Decision

### Recommendation: **READY FOR ONE-TIME HOLDOUT EVALUATION** (Requires Explicit Human Authorization)

### Verification of Frozen Pre-requisites
1. **Deployment Checkpoint:** Frozen at `models/stage2_bilstm_deployment.pth` (`SHA256: 0bd81731...`).
2. **Model Architecture:** Frozen as EfficientNet-B0 + BiLSTM + Global Mean Pooling.
3. **Preprocessing Pipeline:** Frozen ($[200, 1800]$ windowing, dynamic range $[0, 1]$, resize $224 \times 224$).
4. **Sequence Validation:** Frozen via `CTSequenceValidator` enforcing craniocaudal ordering.
5. **Operating Threshold:** Frozen at $\tau = 0.50$.
6. **Evaluation Metrics:** Frozen (Macro F1, ROC-AUC, PR-AUC, Sensitivity, Specificity, Confusion Matrix).
7. **Patient Aggregation:** Frozen (sequence-level probabilities pooled to patient-level).
8. **Output Format:** Frozen to `reports/evaluation/STAGE_2_HOLDOUT_EVALUATION_REPORT.md`.
9. **Reproducibility:** Frozen (seed 42, deterministic PyTorch ops).

### Clinical & Scientific Boundaries of Holdout Evaluation
- **What Holdout Evaluation Establishes:**
  - Evaluates generalization to an independent, unseen acquisition split from the same source dataset (COVID-CTset).
  - Assesses whether the BiLSTM sequence model overfitted to the 122 development patients.
- **What Holdout Evaluation CANNOT Establish:**
  - It does **NOT** establish clinical safety or diagnostic efficacy.
  - It does **NOT** evaluate cross-center, cross-scanner generalization (GE vs Siemens vs Philips scanners).
  - It does **NOT** test discrimination against other pulmonary conditions (e.g., bacterial pneumonia, ARDS, COPD, interstitial lung disease).
  - It cannot replace prospective clinical trials.

---

## 10. Portfolio Deployment Decision

### Recommendation: **PORTFOLIO DEMO READY**

### Reasoning
- The application represents a high-caliber research laboratory and clinical workstation hybrid.
- Real-time sequence inference runs smoothly locally ($~133\text{ ms/slice}$).
- Dual themes and dark CT viewport present a polished, professional aesthetic.
- Prominent research qualifiers ensure responsible academic presentation.
- **Distinction:** PulmoVision is technically ready for portfolio demonstration as an AI medical imaging research prototype, but remains strictly non-diagnostic.

---

## 11. Remaining Risks and Limitations

1. **Single-Center Dataset Bias:** The COVID-CTset dataset originated from a single clinical source in Iran. True multicenter generalization remains unverified.
2. **Single-Slice Fallback ($T=1$):** Sequences with only 1 slice bypass temporal BiLSTM recurrence and rely solely on the initial hidden state, resulting in lower confidence.
3. **Uncalibrated Model Scores:** Sigmoid outputs represent raw discriminative network scores, not true Bayesian posterior probabilities.
4. **Lack of Contrast / Scanner Metadata:** Scans lack full DICOM header metadata (e.g., slice thickness, kVp, reconstruction kernel).

---

## 12. Recommended Final Action Sequence

| Priority | Action | Type | Prerequisite |
| :---: | :--- | :---: | :--- |
| **1** | **Commit Implementation Changes** | Essential | Developer approval of diff. |
| **2** | **Merge `feature/cnn-bilstm` into `main`** | Essential | Successful implementation commit. |
| **3** | **Freeze Research Artifacts & Final Documentation** | Essential | Clean `main` branch. |
| **4** | **Conduct One-Time Sealed Holdout Evaluation** | Optional / Gated | Explicit developer authorization to unseal `test1.csv`. |
| **5** | **Deploy / Package Portfolio Demonstration** | Recommended | Merged `main` branch. |

---

## 13. Explicit Decisions Requiring Human Authorization

The following actions have been prepared and audited, but will **NOT** be executed until explicit, separate human authorization is received:

1. **Staging and committing the working tree files to `feature/cnn-bilstm`.**
2. **Checking out `main` and merging `feature/cnn-bilstm`.**
3. **Unsealing `test1.csv` and executing the final holdout evaluation script.**
4. **Publishing or deploying the Streamlit application to external hosting.**

